Need a specific person's email?
Browse Astellas Engineered Small Molecules U.K. Ltd.'s employee directory (about 15 employees) and reveal verified emails free.
Astellas Engineered Small Molecules U.K. Ltd.'s most common email format is First.Last@astellas.com (ex. John.Doe@astellas.com), used for 93% of astellas.com addresses. Astellas Engineered Small Molecules U.K. Ltd. uses 6 email patterns across 2 domains: astellas.com and nannatherapeutics.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of astellas.com |
|---|---|---|
| First.Last@astellas.comMost common | John.Doe@astellas.com | |
| First_Last@astellas.com | John_Doe@astellas.com | |
| FLast@astellas.com | JDoe@astellas.com | |
| First-Last@astellas.com | John-Doe@astellas.com |
| Format | Example | Share of nannatherapeutics.com |
|---|---|---|
| First.Last@nannatherapeutics.comMost common | John.Doe@nannatherapeutics.com | |
| FLast@nannatherapeutics.com | JDoe@nannatherapeutics.com |
Browse Astellas Engineered Small Molecules U.K. Ltd.'s employee directory (about 15 employees) and reveal verified emails free.
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Astellas Engineered Small Molecules U.K. Ltd. is a Cambridge-based biotechnology research unit that operates as a subsidiary of Astellas. It concentrates on the study and development of engineered small molecules with potential therapeutic applications. The unit is described as part of Astellas, and its information page is currently indicated as not active or monitored. Operating within the biotechnology research sector, the unit supports Astellas' broader effort to advance small molecule therapeutics. Based in Cambridge, England, the organization is characterized as a smaller-scale operation within the company's global research network.
Most common format
First.Last@astellas.com
Example: John.Doe@astellas.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.